Cytokines Associated With Cord Blood Cell Therapy for Neonatal Encephalopathy
A Study to Determine if Autologous Umbilical Cord Blood Cell Therapy Alters Serum Levels of Cytokines and Trophic Factors in Neonatal Encephalopathy
Sponsor: Kurashiki Central Hospital
This observational or N/A phase trial investigates Neonatal Encephalopathy (Neonatal Hypoxic-ischemic Encephalopathy) and is currently ongoing. Kurashiki Central Hospital leads this study, which shows 9 recorded versions since 2015 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Oct 2023 — Jul 2024 [monthly]
Unknown Status
-
Nov 2021 — Oct 2023 [monthly]
Unknown Status
Status: Active Not Recruiting → Unknown Status
-
Jan 2021 — Nov 2021 [monthly]
Active Not Recruiting
▶ Show 4 earlier versions
-
Nov 2019 — Jan 2021 [monthly]
Active Not Recruiting
Status: Unknown Status → Active Not Recruiting
-
Apr 2018 — Nov 2019 [monthly]
Unknown Status
Phase: NA → None
-
Mar 2018 — Apr 2018 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2017 — Mar 2018 [monthly]
Recruiting NA
First recorded
Apr 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Kurashiki Central Hospital
- Nagoya University
- National Center for Child Health and Development, Japan
- National Cerebral and Cardiovascular Center, Japan
- Neonatal Encephalopathy Consortium, Japan
- Osaka City General Hospital
- Osaka City University
- Saitama Medical University
- Tokyo University
- Tokyo Women's Medical University
- Yodogawa Christian Hospital
For direct contact, visit the study record on ClinicalTrials.gov .